Flach Cards Collections

BAM 421 Operations Management Unit 4 Examination

BAM 421 Operations Management Unit 4 Examination, BAM 421 Operations Management Unit 4 Examination, BAM 421 Operations Management Unit 4 Examination, BAM 421 Operations Management Unit 4 Examination, BAM 421 Operations Management Unit 4 Examination

2016-09-19 • 5 Cards

BMGT 364 Project Team Creation

BMGT 364 Project Team Creation, BMGT 364 Project Team Creation, BMGT 364 Project Team Creation, BMGT 364 Project Team Creation, BMGT 364 Project Team Creation

2016-09-17 • 5 Cards

MetS and Type 2 Diabetes Mellitus

Define Metabolic Syndrome, __% of Americans over age of 20 have impaired fasting glucose/__% have MetS, Who has the highest rate of MetS, incidence of MetS increases ___-___% from age 20-60, Increase risk of type 2 diabetes by ____ times with MetS, Rule of thumb for determining how many people have MetS, Metabolic Syndrome risk factors: Abdominal Obesity, Metabolic Syndrome risk factors: Hypertriglyceridemia, Metabolic Syndrome risk factors: Low high-density lipoprotein, Metabolic Syndrome risk factors: Elevated BP, Metabolic Syndrome risk factors: Hyperglycemia, Define Diabetes, Type 1 vs Type 2, ___ million americans afflicted by diabetes, ___% have type 2, ___ leading cause of death (diabetes)

2013-06-04 • 34 Cards

Exercise for prevention of T2DM

Hu et al, 1999, Okado et al, 2000, Church et al, 2011, McAuley et al, 2003, Diabetes Prevention Programm, Mechanism, Meex et al, 2010

2012-01-11 • 7 Cards

Physical activity and diabetes

QOF data, Ethnicity, Glucose homeostasis, Frosig and Richter, 2009, Insulin resistance continum, Criteria for diabetes, Criteria for pre-diabetes, Diabetogenic factors, Abate et al, 1995, Benito et al, 2011

2012-01-11 • 10 Cards

rerereree

cxcxcxcxxcxcx, cv

2011-09-20 • 2 Cards

diabetes mellitus- insulins

aspart (analog)/Novolog, extended insulin zinc (ultralente)/ Humulin U, insulin zinc (lente)/Humulin L, insuline glargine/Lantus, intermediate acting insulins, isophane insulin (reg)/ Humulin 50/50, isophane NPH/Humulin 70/30, isophane/Humulin N, lispro (analog)/Humalog, Long-acting insulins, Mixed insulins, rapid acting insulins, reg/Humulin R

2011-04-28 • 13 Cards

Endocrine: DI Diabetes Insipidus (= 2 Exam questions)

______ can be given to potentiate the effects of Vasopressin?, _______ along with a K+ supplement can be used as a treatment for patients with Diabetes Insipidus?, _______ is usually due to the loss of ability to elaborate a concentrated urine of low solute content in the nighttime hours?, ________ Acetate is the drug of choice for treatment of DI?, 1.005 to 1.035 is considered to be a normal or abnormal for urine's specific gravity?, A clinical finding of patients with DI is they often have ______disturbances?, A complication for patients with DI who are taking Diabinese is ______?, A complication of DI is _________?, A complication of DI is Induced water intoxification is due to the _________ therapy?, A complications of DI result in ______?, A defect in the renal system that is considered to have a familial origin which brings on DI is called ______?, A deficency or resistance to _______ or ADH (anti diuretic hormone) is considered DI?, A deficiency in ADH secretion can result in the clinical finding of ______ Insipidus?, A nurse would want to place a patient with nocturia by the ______ whenever possible?, A nursing goal when taking care of a patient with DI is to control _____ balance and prevent further dehydration?

2011-04-28 • 73 Cards

Winter Term Week 2 Diabetes Prescription

Detemir, Exenatide, Glargine, Glimepiride, Glipizide, Glyburide, Lispro, Metformin, NPH, Pioglitazone, Pramlintide, Regular, Rosiglitazone, Sitagliptin

2011-04-28 • 14 Cards

Diabetes part 1

Blood Sugar, Calorie, Cellular Respiration, Diabetes, Diffusion, Equilibrium, Homeostasis, Insulin, Osmosis

2011-04-28 • 9 Cards

Glucose lowering agents

a-Glucosidase inhibitor, Biguanides, Meglitinide, Sulfonylurea, Thiazolidinediones

2011-04-28 • 5 Cards

Drugs in Diabetes

Alpha Glucosidase Inhibitors (drugs), Alpha Glucosidase Inhibitors AE, Alpha Glucosidase Inhibitors Contraindications, Alpha Glucosidase Inhibitors Dosing, Alpha Glucosidase Inhibitors Drug interactions, Alpha Glucosidase Inhibitors MOA, Alpha Glucosidase Inhibitors Monitoring, Alpha Glucosidase Inhibitors Place in Therapy, Amylin Analogs AE, Amylin Analogs Contra/Precautions, Amylin Analogs Dosing Type 1, Amylin Analogs Dosing Type 2, Amylin Analogs Drugs, Amylin Analogs MOA, Amylin Analogs Patient Counsel

2011-04-28 • 66 Cards

Diabetes 3 oral drugs

Alpha-Glucosidase Inhibitors, Alpha-Glucosidase Inhibitors, Alpha-Glucosidase Inhibitors, Biguanides, Biguanides-Metformin (Glucophase, Glucophage, First Generation Sulfonylureas, First Generation Sulfonylureas, First Generation Sulfonylureas, First Generation Sulfonylureas and Second-Generation Sulfonylureas, Second-Generation Sulfonylureas, Second-Generation Sulfonylureas, Second-Generation Sulfonylureas, Second-Generation Sulfonylureas

2011-04-28 • 13 Cards

Diabetes Insulin 3

Intermediate-Acting (Human), Long-Acting, Rapid-Acting, Regular or Short-Acting, Very Long Acting

2011-04-28 • 5 Cards

NRSG 1024 Drug Therapy for Endocrine Disorders-Diabetes

Action of glitazones/TZD, Alpha-glucosidase inhibitors action, Alpha-glucosidase inhibitors adverse effects, Alpha-glucosidase inhibitors examples, another name for glitazones, Biguannide action (metformin), Biguannide example, Blood glucose goal 2 hours after meals, Blood glucose goal at bedtime, Blood glucose goal for before meals, Blood sugar level in hyperglycemia, Blood sugar level in hypoglycemic state, Causes of hyperglycemia, Causes of hypoglycemia, Characteristics of type 2 DM

2011-04-28 • 52 Cards